Rennes University Hospital

The Rennes University Hospital (French: Centre hospitalier universitaire de Rennes or CHU Rennes) is a university hospital in Rennes in France. It employs 7,700 people[1] and processes nearly 1,500 hospitalisations per day. It was the second largest employer in the Rennes region.[2] It is one of 42 French hospital equipped with the da Vinci Surgical System.

Centre hospitalier universitaire de Rennes
Main building of the Hospital Pontchaillou
Map
Geography
LocationRennes, Brittany, France
Coordinates48°07′15″N 1°41′47″W / 48.12083°N 1.69637°W / 48.12083; -1.69637
Organisation
TypeTeaching, CHU
Services
Emergency departmentYes
Links
Websitewww.chu-rennes.fr
ListsHospitals in France

In 2014, the Rennes University Hospital was ranked in the top 10 hospitals in France.[3]

Research

edit

Research at CHU Rennes has included a study of the efficacy of nalmefene.[4][5]

In 2016, a facility run by the private contract research organization Biotrial, running clinical trials required patients to be admitted to CHU Rennes.[6] The facility ran a phase one study into a new drug being developed by Bial that targets the human endocannabinoid system.[7] The study failed catastrophically, leaving six subjects hospitalized and one brain dead.[8][9]

See also

edit

References

edit
  1. ^ Chiffres clefs 2007, www.chu-rennes.fr
  2. ^ Le pays de Rennes, INSEE, p. 113.
  3. ^ Le Point, magazine. "Hôpitaux - L'actualité Santé – Le Point".
  4. ^ "Study questions drug for alcohol cravings". news.
  5. ^ "PLOS Medicine".
  6. ^ "Rennes. Biotrial, un acteur important des essais thérapeutiques". Ouest-France.fr.
  7. ^ Lizzie Dearden (15 January 2016). "France clinical trial: Prosecutors investigating 'accident' as Biotrial defends drug testing safety record". The Independent.
  8. ^ "DIRECT- Accident thérapeutique à Rennes : les patients sont de l'Ouest". Ouest-France.fr.
  9. ^ "6 Hospitalized, One of Them Brain-Dead, After Drug Trial in France". The New York Times. 16 January 2016.
edit